rethinkPeptides Search
Menu
Research citation

Development and Mechanistic Evaluation of Cathepsin B-Activatable Peptide-Drug Conjugate PROTACs for Targeted Protein Degradation in Malignant Tumors: Advancing Precision Protein Degradation Therapeutics in Oncology.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Development and Mechanistic Evaluation of Cathepsin B-Activatable Peptide-Drug Conjugate PROTACs for Targeted Protein Degradation in Malignant Tumors: Advancing Precision Protein Degradation Therapeutics in Oncology.

Small (Weinheim an der Bergstrasse, Germany), 22(4), e06562

Citation

Zhang, Qingqing; Liu, Yu; Zhang, Jie; Dong, Hengtao; Pan, Xiaoyan; Zhang, Jie. (2026). Development and Mechanistic Evaluation of Cathepsin B-Activatable Peptide-Drug Conjugate PROTACs for Targeted Protein Degradation in Malignant Tumors: Advancing Precision Protein Degradation Therapeutics in Oncology.. Small (Weinheim an der Bergstrasse, Germany), 22(4), e06562. https://doi.org/10.1002/smll.202506562